Definitive Healthcare (NASDAQ:DH) Stock Price Down 4.9% – Here’s Why

Definitive Healthcare Corp. (NASDAQ:DH)’s share price was down 4.9% during mid-day trading on Wednesday . The company traded as low as $4.76 and last traded at $4.77. Approximately 104,155 shares changed hands during mid-day trading, a decline of 86% from the average daily volume of 756,992 shares. The stock had previously closed at $5.01.

Analysts Set New Price Targets

A number of brokerages have issued reports on DH. Needham & Company LLC restated a “hold” rating on shares of Definitive Healthcare in a research report on Thursday, January 16th. Barclays restated an “underweight” rating and set a $4.00 price objective on shares of Definitive Healthcare in a research note on Monday, January 13th. Finally, Stephens began coverage on Definitive Healthcare in a research report on Friday, December 20th. They set an “equal weight” rating and a $5.00 target price for the company. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $5.72.

Definitive Healthcare Trading Down 0.5 %

The firm’s fifty day simple moving average is $4.41 and its 200-day simple moving average is $4.45. The company has a debt-to-equity ratio of 0.33, a quick ratio of 2.49 and a current ratio of 2.49. The stock has a market cap of $565.24 million, a P/E ratio of -1.59, a price-to-earnings-growth ratio of 3.70 and a beta of 1.41.

Definitive Healthcare (NASDAQ:DH) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.08 by ($0.03). Definitive Healthcare had a negative net margin of 142.38% and a positive return on equity of 1.76%. The firm had revenue of $62.70 million for the quarter, compared to the consensus estimate of $61.66 million. During the same period last year, the company posted $0.01 EPS. Equities research analysts expect that Definitive Healthcare Corp. will post 0.15 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider William Moschella sold 45,000 shares of the business’s stock in a transaction dated Tuesday, December 3rd. The stock was sold at an average price of $4.70, for a total value of $211,500.00. Following the completion of the sale, the insider now directly owns 433,830 shares of the company’s stock, valued at $2,039,001. The trade was a 9.40 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 14.84% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Definitive Healthcare

A number of hedge funds have recently added to or reduced their stakes in DH. Rhumbline Advisers increased its position in shares of Definitive Healthcare by 5.2% during the fourth quarter. Rhumbline Advisers now owns 81,316 shares of the company’s stock worth $334,000 after acquiring an additional 4,034 shares in the last quarter. SG Americas Securities LLC increased its holdings in Definitive Healthcare by 44.6% during the 4th quarter. SG Americas Securities LLC now owns 27,189 shares of the company’s stock worth $112,000 after purchasing an additional 8,387 shares in the last quarter. Nisa Investment Advisors LLC raised its stake in shares of Definitive Healthcare by 3,652.7% in the fourth quarter. Nisa Investment Advisors LLC now owns 6,980 shares of the company’s stock worth $29,000 after purchasing an additional 6,794 shares during the last quarter. Hennion & Walsh Asset Management Inc. lifted its holdings in shares of Definitive Healthcare by 34.1% in the fourth quarter. Hennion & Walsh Asset Management Inc. now owns 50,886 shares of the company’s stock valued at $209,000 after purchasing an additional 12,946 shares in the last quarter. Finally, JPMorgan Chase & Co. boosted its position in shares of Definitive Healthcare by 431.7% during the third quarter. JPMorgan Chase & Co. now owns 222,090 shares of the company’s stock valued at $993,000 after buying an additional 180,323 shares during the last quarter. Institutional investors and hedge funds own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.